title: Spironolactone in patients with heart failure.
authors.forename: R J
authors.initials: RJ
authors.lastname: Larkin
authors.forename: S A
authors.initials: SA
authors.lastname: Atlas
authors.forename: T J
authors.initials: TJ
authors.lastname: Donohue
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D013148:Spironolactone / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D013148:Spironolactone